期刊文献+

MicroRNA对脓毒症炎症因子的调控 被引量:6

MicroRNA in the regulation of inflammatory factors in sepsis
在线阅读 下载PDF
导出
摘要 在过去的几十年里关于脓毒症的研究取得了巨大的进展,但是脓毒症休克发生后尽管给予很多治疗,其死亡率仍然保持在50%左右。脓毒症的发生机制极其复杂,近年的研究显示其与调节失控的炎症反应有密切的关系。已经证实MicroRNA可以在转录后水平调节生物蛋白质的表达。近年研究发现MicroRNA可以通过转录后水平下调炎症因子以及炎症因子信号通路的受体来控制失衡的炎症反应,有望成为治疗脓毒症的一条更合适的途径。本文就MicroRNA在脓毒症炎症因子调节失衡中作用的研究近况做一综述。 There are some progresses on the study of Sepsis in several decades. Although we had given our patients a lot of treatments, the mortality rate of Sepsis shock remained as high as 50%. The mechanism of sepsis is very complex. Some researches indicated the mechanism of sepsis have close relation without immune response. It has been confirmed that microRNAs can adjust diverse biological processes at the level of post - transcriptional repression. In recent years we have found that microRNAs could decline sepsis of cytokines and signaling pass way receptor in some experiments. MicroRNA can open up a new way for curing sepsis in more up - stream. In this article,we summarize the function of microRNA in control of inflammation in sepsis.
出处 《中国急救医学》 CAS CSCD 北大核心 2010年第3期271-274,共4页 Chinese Journal of Critical Care Medicine
关键词 微小RNA 炎症 脓毒症 MicroRNA Inflammation Sepsis
  • 相关文献

参考文献23

  • 1Johnson SM,Grosshans H,Shingara J,et al.RAS is regulated by the let 27 microRNA family[J].Cell,2005,120(5):635-647.
  • 2Van Rooij E,Sutherland LB,Liu N,et al.A signature pattern of stress responsive microRNAs that can evoke cardiac hype-rophyand heart failure[J].Proc Natl Acad Sci USA,2006,103(48):218-255.
  • 3Lee RC,Feinbaum RL,Ambros V.The elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell,1993,75(5):843-854.
  • 4Reinhart SJ,Slack FJ,Basson M,et al.The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans[J].Nature,2000,403(6772):901-906.
  • 5Bentwich I,Avniel A,Karov Y,et al.Identification of hundreds of conserved and nonconserved human microRNAs[J].Nature Genetics,2005,37(7):766-770.
  • 6Berezikov E,Guryev V,van de Belt J,et al.Phylogenetic shadowing and computational identification of human microRNA genes[J].Cell,2005,120(1):21-24.
  • 7Miranda KC,Huynh T,Tay Y,et al.A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes[J].Cell,2006,126(6):1203-1217.
  • 8Zhao Y,Srivastava D.A developmental view of microRNA function[J].Trends Biochem Sci,2007,32(4):189-197.
  • 9Taganov KD,Boldin MP,Baltimore D,et al.MicroRNAs and immunity:tiny players in a big field[J].Immunity,2007,26(2):133-137.
  • 10Du T,Zamore PD.microPrimer:the biogenesis and function of miRNA[J].Development,2005,132(21):4645-4652.

二级参考文献15

  • 1Ni Choileain N,Redmond HP.The immunological consequences of injury.Surg,2006,4(1):23-31.
  • 2Mark TL,Timothy EA.Genomic polymorphisms in sepsis.Crit Care Med,2004,32:569-579.
  • 3Penglin Ma,Dechang Chen,Jiaqi Pan,et al.Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients.Crit Care Med,2002,30:1046-1050.
  • 4Eichacker PQ,Parent C,Kalil A,et al.Risk and the efficacy of antiinflammatory agents:retrospective and confirmatory studies of sepsis.Am J Respir Crit Care Med,2002,166:1197-1205.
  • 5Penglin Ma,Danner RL.The many faces of sepsis-induced vascular failure.Crit Care Med,2002,30:947-949.
  • 6Avontuur JA,Tutein Nolthenius RP,van Bodegom JW.et al.Prolonged inhibition of nitric oxide synthesis in severe septic shock:a clinical study.Crit Care Med,1998,26:660-667.
  • 7Bernard GR.Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med,2001,344:699-709.
  • 8American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:definitions for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992,20:864-874.
  • 9Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med,2003,31:1250-1256.
  • 10Summer WR.Severe sepsis:new concepts in pathogenesis and management.Am J Med Sci,2004,328:193-195.

共引文献17

同被引文献90

  • 1姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3):185-186. 被引量:118
  • 2Cohen J. The immunopathogenesis of sepsis [J]. Nature, 2002,420 (6917) : 885-891.
  • 3Brun-Buisson C. The epidemiology of the systemic inflammatoryresponse [ J]. Intensive Care Med, 2000, 26 Suppl 1 : S64-74.
  • 4Seeling M, Eggers V, Spies C. Surviving sepsis campaign:guideline clarification [ J]. Crit Care Med, 2008, 36 (8) : 2490.
  • 5Hotchkiss RS, Kari IE. The pathophysioiogy and treatment of sepsis[J]. N Engl J Med, 2003,348 (2) : 138-150.
  • 6Xiong Y, Fang JH, Yun JP, et al. Effects of microHNA-29 onapoptosis,tumorigenicity, and prognosis of hepatocellular carcinoma[J]. Hepatology ( 2010, 51 (3) : 836-845.
  • 7Efron PA,Tinsley K,Minnich DJ, et al . Increased lymphoid tissueapoptosis in baboons with bacteremic shock [J]. Shock, 2004 , 21(6): 566-571.
  • 8Hotchkiss RS, Osmon SB, Chang KC, et al. Acceleratedlymphocyte death in sepsis occurs by both the death receptor andmitochondrial pathways [J], J Immunol, 2006,174 (8): 5110-5118.
  • 9Bartel DP. MicroRNAs: genomies, biogenesis, mechanism, andfunction [J]. Cell, 2004,116 (2) : 281-297.
  • 10Ambros V. The functions of animal microRNAs [ J ]. Nature,2004 , 431 (7006): 350-355.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部